Rabbit Recombinant Monoclonal FAM160A2 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
C11orf56, FAM160A2, KIAA1759, FHIP1B, FHF complex subunit HOOK-interacting protein 1B, FTS- and Hook-interacting protein, FHIP
- WB
Supplier Data
Western blot - Anti-FAM160A2 antibody [EPR13604] (AB184160)
All lanes:
Western blot - Anti-FAM160A2 antibody [EPR13604] (ab184160) at 1/1000 dilution
Lane 1:
HeLa lysate at 10 µg
Lane 2:
Human fetal brain lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 106 kDa
false
- WB
CiteAb
Western blot - Anti-FAM160A2 antibody [EPR13604] (AB184160)
FAM160A2 western blot using anti-FAM160A2 antibody [EPR13604] ab184160. Publication image and figure legend from Redwine, W. B., DeSantis, M. E., et al., 2017, Elife, PubMed 28718761.
ab184160 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab184160 please see the product overview.
KIF1C is a novel HOOK3-interacting protein.sfGFP-3×FLAG and full length (FL) HOOK3, HOOK3 (1–552), and HOOK3 (553–718) all tagged with sfGFP and 3×FLAG were immunoprecipitated with α-FLAG antibodies from transiently transfected HEK-293T cells. Western blots with α-HC, α-FAM160A2, α-KIF1C, and α-FLAG antibodies were used to determine which proteins co-immunoprecipitated with each HOOK3 construct.DOI : http : //dx.doi.org/10.7554/eLife.28257.015
false
Related conjugates and formulations (1)
-
Anti-FAM160A2 antibody [EPR13604] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FAM160A2 contributes to cellular organization and homeostasis. It assists in regulating intracellular signaling pathways possibly working as part of larger protein complexes. This involvement in cellular signaling pathways implies that FAM160A2 plays a part in maintaining the normal function of cells. It can impact processes such as signal transduction and cellular communication though its precise biological functions remain under study.
Pathways
Research indicates that FAM160A2 participates in signaling cascades such as the MAPK pathway and the apoptosis pathway. Through the MAPK pathway it may act alongside proteins like ERK1/2 to regulate cellular responses to stimuli including stress and growth signals. In the apoptosis pathway FAM160A2's role possibly associates with proteins like Bcl-2 influencing cell death decisions which are critical for tissue development and immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Molecular biology of the cell 31:963-979 PubMed32073997
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 6: PubMed28718761
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com